ABBV-744 is a BDII-selective BET bromodomain inhibitor that is being investigated to treat AML and metastic castration-resistant prostate cancer.
Reference
[1]. FIDANZE, Steven D., et al. BROMODOMAIN INHIBITORS. WO 2017177955 A1.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1mg | ¥411.00 | 现货 | 1 | |
| 5mg | ¥1,125.00 | 现货 | 1 | |
| 10mg | ¥1,800.00 | 现货 | 1 | |
| 25mg | ¥3,555.00 | 现货 | 1 | |
| 50mg | ¥4,815.00 | 现货 | 1 | |
| 10mM (in 1mL DMSO) | ¥1,217.00 | 现货 | 1 |
















ABBV-744 is a BDII-selective BET bromodomain inhibitor that is being investigated to treat AML and metastic castration-resistant prostate cancer.
Reference
[1]. FIDANZE, Steven D., et al. BROMODOMAIN INHIBITORS. WO 2017177955 A1.